Key facts
- This page summarizes Michael J. Fox's Form 3 filing for Cue Biopharma, Inc. (CUE).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jun 2024, 16:00.
Michael J. Fox - 05 Jun 2024 Form 3 Insider Report for Cue Biopharma, Inc. (CUE)
- Reporting relationship
- Director
- Issuer ticker
- CUE
- Reported as of
- 05 Jun 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Jun 2024, 16:00:05 UTC
- Prior SEC filing
- 28 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael J. Fox by Colin Sandercock, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael J. Fox filed Form 3 for Cue Biopharma, Inc. (CUE) on 07 Jun 2024.
Change
- Previous filing in this sequence was filed on 28 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CUE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,000,000
- Date
- 05 Jun 2024
- Ownership
- By Park City Capital Offshore Master, Ltd.
- Footnotes
- F1
CUE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100,000
- Date
- 05 Jun 2024
- Ownership
- By MF Capital Partners, LLC
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reporting person is the managing member of the investment manager of the fund that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F2
The reporting person is the managing member of the fund that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
SEC remarks
Exhibit 24.1 - Power of Attorney